Pharmacy
News
Tazemetostat receives fast track designation for DLBCL
The US Food and Drug Administration (FDA) has granted fast track designation for tazemetostat as a treatment for patients with relapsed or...
News
EC grants ixazomib conditional approval to treat MM
The European Commission (EC) has granted conditional marketing authorization for ixazomib (NinlaroTM) to be used in combination with lenalidomide...
News
AEs from anticoagulants common cause of ED visits
caring for a patient Photo by Tom Watanabe A new study has revealed which drugs most commonly caused adverse events (AEs) leading to emergency...
News
EC grants drug orphan designation for PNH
The European Commission (EC) has granted orphan drug designation to RA101495 for the treatment of paroxysmal nocturnal hemoglobinuria (PNH)....
News
EC approves nivolumab for relapsed/refractory cHL
Photo from Business Wire The European Commission (EC) has approved nivolumab (Opdivo) for the treatment of adults with relapsed or refractory...
News
FDA approves new uses for drug in MM
Photo courtesy of Janssen The US Food and Drug Administration (FDA) has approved new indications for the monoclonal antibody daratumumab (...
News
Drug approved to treat hemophilia A in Kuwait
(Elocta) packaging Photo courtesy of Sobi The Ministry of Health in Kuwait has approved efmoroctocog alfa (Elocta®), a recombinant human factor...
News
Company withdraws application for eryaspase in ALL
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) asked for additional data on eryaspase, but ERYTECH...
News
FDA grants priority review for midostaurin
The US Food and Drug Administration (FDA) has granted priority review for the new drug application for midostaurin (PKC412) as a treatment for...
News
EMA recommends orphan status for drug in AML
The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has recommended that BP1001 receive orphan designation as a...
News
CHMP recommends drug for hemophilia A
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for lonoctocog alfa...